{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:32:56Z","timestamp":1784867576195,"version":"3.55.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","award":["MOP-97946"],"award-info":[{"award-number":["MOP-97946"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["12J00172"],"award-info":[{"award-number":["12J00172"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008731","name":"Nakatomi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002975","name":"Dainippon Sumitomo Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004095","name":"Kyowa Hakko Kirin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wiley Japan"},{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"crossref","award":["RO1MH084886"],"award-info":[{"award-number":["RO1MH084886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jagp.2016.03.013","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T01:17:54Z","timestamp":1462065474000},"page":"923-939","source":"Crossref","is-referenced-by-count":22,"title":["\u0392-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review"],"prefix":"10.1016","volume":"24","author":[{"given":"Jun Ku","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Plitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Uy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Gerretsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Caravaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Mallar","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Graff-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2016.03.013_bib0010","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archpsyc.60.12.1187","article-title":"Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies","volume":"60","author":"Sullivan","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1192\/S0007125000292714","article-title":"The epidemiology of early schizophrenia. Influence of age and gender on onset and early course","author":"Hafner","year":"1994","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0925-4927(97)00012-7","article-title":"Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia","volume":"74","author":"DeLisi","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jagp.2016.03.013_bib0025","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/schbul\/sbu070","article-title":"Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage","volume":"40","author":"Kochunov","year":"2014","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jagp.2016.03.013_bib0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1192\/S0007125000293148","article-title":"Neurodevelopmental schizophrenia: the rediscovery of dementia praecox","author":"Murray","year":"1994","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0035","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/archpsyc.1984.01790170060007","article-title":"The Chestnut Lodge follow-up study. II. Long-term outcome of schizophrenia and the affective disorders","volume":"41","author":"McGlashan","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0040","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archpsyc.1984.01790170047006","article-title":"The Chestnut Lodge follow-up study. I. Follow-up methodology and study sample","volume":"41","author":"McGlashan","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/schbul\/sbn127","article-title":"Neurocognitive decline in early-onset schizophrenia compared with ADHD and normal control subjects: evidence from a 13-year follow-up study","volume":"36","author":"Oie","year":"2010","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jagp.2016.03.013_bib0050","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1192\/bjp.152.4.466","article-title":"Age disorientation in chronic schizophrenia is not associated with pre-morbid intellectual impairment or past physical treatment","volume":"152","author":"Buhrich","year":"1988","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1176\/ajp.152.2.197","article-title":"Severity of symptoms in chronically institutionalized geriatric schizophrenic patients","volume":"152","author":"Davidson","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2009.10.013","article-title":"Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients","volume":"116","author":"Rapp","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jagp.2016.03.013_bib0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/JGP.0b013e31823bc08c","article-title":"Age-associated differences in cognitive performance in older patients with schizophrenia: a comparison with healthy older adults","volume":"20","author":"Loewenstein","year":"2012","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-3223(98)00273-X","article-title":"Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients","volume":"45","author":"Harvey","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11126-011-9189-8","article-title":"Is there evidence for late cognitive decline in chronic schizophrenia?","volume":"83","author":"Shah","year":"2012","journal-title":"Psychiatr Q"},{"key":"10.1016\/j.jagp.2016.03.013_bib0080","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0006-3223(01)01067-8","article-title":"Longitudinal study of brain morphology in first episode schizophrenia","volume":"49","author":"Lieberman","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.schres.2008.11.026","article-title":"Progressive brain structural changes mapped as psychosis develops in \u201cat risk\u201d individuals","volume":"108","author":"Sun","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jagp.2016.03.013_bib0090","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.biopsych.2011.11.026","article-title":"Cortical volume, surface area, and thickness in schizophrenia and bipolar disorder","volume":"71","author":"Rimol","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0095","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.biopsych.2012.10.002","article-title":"Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression","volume":"73","author":"Kochunov","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0100","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.biopsych.2013.08.020","article-title":"Psychosis in Alzheimer's disease","volume":"75","author":"Murray","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0105","doi-asserted-by":"crossref","first-page":"17648","DOI":"10.1073\/pnas.1410378111","article-title":"A common brain network links development, aging, and vulnerability to disease","volume":"111","author":"Douaud","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jagp.2016.03.013_bib0110","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/jamapsychiatry.2015.1546","article-title":"Long-term risk of dementia in persons with schizophrenia: a Danish population-based cohort study","volume":"72","author":"Ribe","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0115","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00005072-199409000-00003","article-title":"Alzheimer's disease: a central role for amyloid","volume":"53","author":"Selkoe","year":"1994","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jagp.2016.03.013_bib0120","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1074\/jbc.270.13.7013","article-title":"Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43)","volume":"270","author":"Gravina","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jagp.2016.03.013_bib0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0006-291X(02)02635-9","article-title":"Alpha- and beta-secretase: profound changes in Alzheimer's disease","volume":"299","author":"Tyler","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jagp.2016.03.013_bib0130","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jagp.2016.03.013_bib0135","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbadis.2011.11.005","article-title":"PET amyloid-beta imaging in preclinical Alzheimer's disease","volume":"1822","author":"Vlassenko","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jagp.2016.03.013_bib0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1385\/MN:24:1-3:087","article-title":"CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease","volume":"24","author":"Blennow","year":"2001","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jagp.2016.03.013_bib0145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jagp.2016.03.013_bib0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JAD-2012-111361","article-title":"Amyloid-beta oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease","volume":"29","author":"Santos","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2016.03.013_bib0155","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1096\/fj.09-150359","article-title":"High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients","volume":"24","author":"Fukumoto","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.jagp.2016.03.013_bib0160","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0197-4580(96)00170-4","article-title":"Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease","volume":"17","author":"Cummings","year":"1996","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jagp.2016.03.013_bib9000","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/mp.2014.9","article-title":"Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study","volume":"19","author":"Doraiswamy","year":"2014","journal-title":"Mol Psychiatry"},{"issue":"suppl 1","key":"10.1016\/j.jagp.2016.03.013_bib0165","first-page":"S79","article-title":"Amyloid-beta and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms","volume":"33","author":"Hampel","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2016.03.013_bib0170","first-page":"861","article-title":"Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia","volume":"154","author":"Baldessarini","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0175","first-page":"e123","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"3","author":"Moher","year":"2009","journal-title":"Open Med"},{"key":"10.1016\/j.jagp.2016.03.013_bib0180","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jagp.2013.12.093","article-title":"Amyloid deposition in older adults with chronic schizophrenia","volume":"22","author":"Weldon","year":"2014","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00002093-199408040-00001","article-title":"Neurofibrillary pathology in brains of elderly schizophrenics treated with neuroleptics","volume":"8","author":"Wisniewski","year":"1994","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jagp.2016.03.013_bib0190","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00401-001-0496-2","article-title":"Neuritic pathology is lacking in the entorhinal cortex, subiculum and hippocampus in middle-aged adults with schizophrenia, bipolar disorder or unipolar depression","volume":"103","author":"Damadzic","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jagp.2016.03.013_bib0195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-0270(01)00429-0","article-title":"Pourdihimi B: senile plaques exert no mass lesion effect on surrounding neurons","volume":"110","author":"Casanova","year":"2001","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.jagp.2016.03.013_bib0200","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00401-001-0468-6","article-title":"Disentangling the pathology of schizophrenia and paraphrenia","volume":"103","author":"Casanova","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jagp.2016.03.013_bib0205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1155\/1999\/256382","article-title":"Spatial analysis of the neuronal density of aminergic brainstem nuclei in primary neurodegenerative and vascular dementia: a comparative immunocytochemical and quantitative study using a graph method","volume":"19","author":"Yang","year":"1999","journal-title":"Anal Cell Pathol"},{"key":"10.1016\/j.jagp.2016.03.013_bib9005","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/oxfordjournals.schbul.a033330","article-title":"Postmortem studies in schizophrenia","volume":"24","author":"Powchik","year":"1998","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jagp.2016.03.013_bib0275","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/gps.2575","article-title":"Alzheimer's CSF markers in older schizophrenia patients","volume":"26","author":"Frisoni","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0210","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/jnp.3.4.383","article-title":"The nucleus basalis of Meynert, senile plaques, and intellectual impairment in schizophrenia","volume":"3","author":"El-Mallakh","year":"1991","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jagp.2016.03.013_bib0215","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archpsyc.55.3.205","article-title":"Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases","volume":"55","author":"Purohit","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0220","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1176\/appi.ajp.160.5.867","article-title":"Amyloid beta pathology in Alzheimer's disease and schizophrenia","volume":"160","author":"Religa","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0225","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0197-4580(94)90024-8","article-title":"Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions","volume":"15","author":"Arnold","year":"1994","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jagp.2016.03.013_bib0230","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archpsyc.55.3.225","article-title":"Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia","volume":"55","author":"Arnold","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0235","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0920-9964(98)00028-0","article-title":"Autopsy study of Alzheimer's disease brain pathology in schizophrenia","volume":"31","author":"Niizato","year":"1998","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jagp.2016.03.013_bib0240","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00019442-200403000-00008","article-title":"Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia","volume":"12","author":"Nishioka","year":"2004","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0245","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1176\/ajp.155.11.1536","article-title":"Senile degeneration and cognitive impairment in chronic schizophrenia","volume":"155","author":"Dwork","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0250","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/schbul\/19.4.805","article-title":"Alzheimer-type neuropathology in elderly schizophrenia patients","volume":"19","author":"Prohovnik","year":"1993","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jagp.2016.03.013_bib0255","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-1781(93)90029-G","article-title":"A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia","volume":"49","author":"Casanova","year":"1993","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jagp.2016.03.013_bib0260","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1002\/elps.201200307","article-title":"Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia","volume":"33","author":"Albertini","year":"2012","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jagp.2016.03.013_bib0265","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jagp.2012.08.020","article-title":"Comparison between clinical diagnosis and CSF biomarkers of Alzheimer disease in elderly patients with late onset psychosis: Helsinki Old Age Psychosis Study (HOPS)","volume":"22","author":"Seppala","year":"2014","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0270","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0006-3223(93)90291-K","article-title":"Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study","volume":"33","author":"Purohit","year":"1993","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0280","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/jamapsychiatry.2015.1745","article-title":"Dementia in patients with schizophrenia: evidence for heterogeneity","volume":"72","author":"Lyketsos","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0285","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.pnpbp.2006.04.007","article-title":"Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of Alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications","volume":"30","author":"Deutsch","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0290","doi-asserted-by":"crossref","first-page":"13568","DOI":"10.1021\/bi9617264","article-title":"Nicotine inhibits amyloid formation by the beta-peptide","volume":"35","author":"Salomon","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0295","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1471-4159.1997.68010333.x","article-title":"Inhibition of beta-amyloid formation by haloperidol: a possible mechanism for reduced frequency of Alzheimer's disease pathology in schizophrenia","volume":"68","author":"Higaki","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.jagp.2016.03.013_bib0300","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2005.02.010","article-title":"A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors","volume":"76","author":"de Leon","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jagp.2016.03.013_bib0305","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1749-6632.2002.tb04178.x","article-title":"Nicotine reduces the secretion of Alzheimer's beta-amyloid precursor protein containing beta-amyloid peptide in the rat without altering synaptic proteins","volume":"965","author":"Lahiri","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jagp.2016.03.013_bib0310","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3233\/JAD-2002-4507","article-title":"Nicotine lowers the secretion of the Alzheimer's amyloid beta-protein precursor that contains amyloid beta-peptide in rat","volume":"4","author":"Utsuki","year":"2002","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2016.03.013_bib0315","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2990.2005.00674.x","article-title":"Attenuation of Abeta deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smoking","volume":"31","author":"Court","year":"2005","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.jagp.2016.03.013_bib0320","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/ncomms2494","article-title":"Smoking exacerbates amyloid pathology in a mouse model of Alzheimer's disease","volume":"4","author":"Moreno-Gonzalez","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jagp.2016.03.013_bib0325","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1523\/JNEUROSCI.2797-06.2006","article-title":"Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease","volume":"26","author":"Green","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.jagp.2016.03.013_bib0330","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/01.wnl.0000172914.08967.dc","article-title":"Aggregation of vascular risk factors and risk of incident Alzheimer disease","volume":"65","author":"Luchsinger","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2016.03.013_bib0335","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bmj.310.6979.555","article-title":"Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men","volume":"310","author":"Rimm","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.jagp.2016.03.013_bib0340","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/tc.8.2.156","article-title":"Passive smoking as well as active smoking increases the risk of acute stroke","volume":"8","author":"Bonita","year":"1999","journal-title":"Tob Control"},{"key":"10.1016\/j.jagp.2016.03.013_bib0345","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1111\/j.1742-4658.2008.06519.x","article-title":"Demonstration of an anti-oxidative stress mechanism of quetiapine: implications for the treatment of Alzheimer's disease","volume":"275","author":"Xu","year":"2008","journal-title":"FEBS J"},{"key":"10.1016\/j.jagp.2016.03.013_bib0350","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0022-510X(96)00018-4","article-title":"Long-term antipsychotic medication of schizophrenics does not promote the development of Alzheimer's disease brain pathology","volume":"138","author":"Niizato","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jagp.2016.03.013_bib0355","first-page":"277","article-title":"Cognitive effects of atypical antipsychotic drugs in first-episode drug-naive schizophrenic patients","volume":"8","author":"Wang","year":"2013","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.jagp.2016.03.013_bib0360","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.schres.2014.06.035","article-title":"Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia\u2014an observational 9-year follow-up study","volume":"158","author":"Husa","year":"2014","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jagp.2016.03.013_bib0365","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/schbul\/sbr189","article-title":"Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data","volume":"39","author":"Sakurai","year":"2013","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jagp.2016.03.013_bib0370","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jamaneurol.2014.1358","article-title":"Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid beta-amyloid 42: a cross-validation study against amyloid positron emission tomography","volume":"71","author":"Palmqvist","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jagp.2016.03.013_bib0375","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","article-title":"Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease","volume":"132","author":"Jack","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jagp.2016.03.013_bib0380","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2004.09.009","article-title":"Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS","volume":"72","author":"Green","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jagp.2016.03.013_bib0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13607863.2015.1081152","article-title":"Social participation predicts cognitive functioning in aging adults over time: comparisons with physical health, depression, and physical activity","volume":"1","author":"Bourassa","year":"2015","journal-title":"Aging Ment Health"},{"key":"10.1016\/j.jagp.2016.03.013_bib0390","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jagp.2016.03.013_bib0395","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jagp.2016.03.013_bib0400","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1017\/S1355617702813248","article-title":"What is cognitive reserve? Theory and research application of the reserve concept","volume":"8","author":"Stern","year":"2002","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.jagp.2016.03.013_bib0405","doi-asserted-by":"crossref","first-page":"113","DOI":"10.15288\/jsa.2006.67.113","article-title":"The effects of acute alcohol consumption, cognitive reserve, partner risk, and gender on sexual decision making","volume":"67","author":"Abbey","year":"2006","journal-title":"J Stud Alcohol"},{"key":"10.1016\/j.jagp.2016.03.013_bib0410","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1176\/ajp.2007.164.3.402","article-title":"Schizophrenia and co-occurring substance use disorder","volume":"164","author":"Green","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0415","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fpsyt.2013.00182","article-title":"A systematic review of cognitive function in first-episode psychosis, including a discussion on childhood trauma, stress, and inflammation","volume":"4","author":"Aas","year":"2014","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0420","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0013-7006(06)76153-X","article-title":"Use of antidepressant drugs in schizophrenic patients with depression","volume":"32","author":"Micallef","year":"2006","journal-title":"Encephale"},{"key":"10.1016\/j.jagp.2016.03.013_bib0425","doi-asserted-by":"crossref","first-page":"14968","DOI":"10.1073\/pnas.1107411108","article-title":"Serotonin signaling is associated with lower amyloid-beta levels and plaques in transgenic mice and humans","volume":"108","author":"Cirrito","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jagp.2016.03.013_bib0430","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12291-008-0071-x","article-title":"The biochemical womb of schizophrenia: a review","volume":"23","author":"Gaur","year":"2008","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.jagp.2016.03.013_bib0435","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/157015911795596595","article-title":"Oxidative stress in schizophrenia","volume":"9","author":"Boskovic","year":"2011","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.jagp.2016.03.013_bib0440","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0896-6273(94)90311-5","article-title":"NMDA receptor channels: subunit-specific potentiation by reducing agents","volume":"12","author":"Kohr","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.jagp.2016.03.013_bib0445","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2006\/248387","article-title":"Altered glutathione redox state in schizophrenia","volume":"22","author":"Yao","year":"2006","journal-title":"Dis Markers"},{"key":"10.1016\/j.jagp.2016.03.013_bib0450","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","article-title":"Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo","volume":"12","author":"Do","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jagp.2016.03.013_bib0455","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neulet.2011.05.027","article-title":"N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder","volume":"499","author":"Dean","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jagp.2016.03.013_bib0460","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","article-title":"N-acetyl cysteine as a glutathione precursor for schizophrenia\u2013a double-blind, randomized, placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0465","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1503\/jpn.100057","article-title":"N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action","volume":"36","author":"Dean","year":"2011","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.jagp.2016.03.013_bib0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2000.0740001.x","article-title":"Apoptosis and the nervous system","volume":"74","author":"Sastry","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.jagp.2016.03.013_bib0475","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.yco.0000218603.25346.8f","article-title":"Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations","volume":"19","author":"Jarskog","year":"2006","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0480","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.pnpbp.2005.03.010","article-title":"Apoptotic mechanisms in the pathophysiology of schizophrenia","volume":"29","author":"Jarskog","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0485","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0006-3223(00)00988-4","article-title":"Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia","volume":"48","author":"Jarskog","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jagp.2016.03.013_bib0490","first-page":"185","article-title":"Neurodevelopment or neurodegeneration: review of theories of schizophrenia","volume":"42","author":"Pino","year":"2014","journal-title":"Acta Esp Psiquiatr"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748116300768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748116300768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T02:19:30Z","timestamp":1567822770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748116300768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":99,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1064748116300768"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2016.03.013","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}